Elixinol Wellness Limited (EXL.AX)
Elixinol Wellness Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Newtown, VIC, AU. The stock last traded at $0.01, down 7.69% on the session, giving a market capitalisation of $2.5M. Its beta of 2.20 implies it has historically moved more than the broad market.
Elixinol Wellness Limited, an entity established in 2017 and headquartered in Sydney, Australia, operates internationally through its subsidiaries. The company is primarily involved in the manufacturing and global distribution of a wide array of hemp-derived products, encompassing nutraceuticals, cosmetics, and various food items. These products are marketed under its distinct brands, Elixinol and Hemp Foods Australia, reaching consumers across the Americas, Europe, and Australia. Its extensive product range features hemp-derived cannabidiol (CBD) items, food products, dietary supplements, and topical skincare solutions. Notably, the company transitioned to its current name in May 2021, having previously been known as Elixinol Global Limited.
Elixinol Wellness Limited is most often compared with the following Healthcare names: